Harnessing potentials of medical biotechnology in delivery of quality health service in Nigeria

Odeyemi, Olumide Adedokun
December 2011
International Journal of Students' Research;Dec2011, Vol. 1 Issue 4, p105
Academic Journal
Biotechnology is the manipulation and application of the whole or a part of a living biological system such as microorganisms, plants and animals for the production of goods and services for the benefits of mankind and society at large. Various aspect of biotechnology has been identified based on their applications in medicine, industry and agriculture. Medical biotechnology involves medical application of biotechnology for disease diagnosis, prevention and treatment. One of the major factors to be considered in delivery of quality health services in developing countries like Nigeria is the rapid diagnosis of diseases and infections. This will in turn help in subsequent rapid treatment and prevention. Molecular diagnostic techniques are vital tools required for detection of diseases and infections. Harnessing inherent potentials of medical biotechnology will help in early detection of diseases such as Acquired Immunodeficiency Syndrome (AIDS), Sexually Transmitted Infections (STI), communicable and infectious diseases in developing countries. It will also help in reducing the work load of diagnostic laboratories. This paper therefore highlights significance of harnessing medical biotechnology in enhancing delivery of quality health service in Nigeria.


Related Articles

  • Positives and Negatives. Diulio, Renee // Clinical Lab Products;Sep2010, Vol. 40 Issue 9, p20 

    This article looks at the advantages and disadvantages of methodologies for diagnosing respiratory viruses. It identifies the benefits of using respiratory viral diagnostics when used appropriately, including improved care, shorter hospital stays and greater cost effectiveness. It also...

  • Molecular Dx vs. "superbugs" & "superdrugs". Bersch, Carren // MLO: Medical Laboratory Observer;Sep2007, Vol. 39 Issue 9, p10 

    The article focuses on the efforts of the experts and healthcare professionals in the U.S. to explore every possibility to find a cure for hospital-acquired infections (HAI) or nosocomial infections. According to the author, industry consolidations, molecular research and development (R&D), and...

  • Future of molecular diagnostics and cancer. Slum, Ronald A. // MLO: Medical Laboratory Observer;Mar2008, Vol. 40 Issue 3, p30 

    The article focuses on the role of molecular diagnostics in the management of patients with such diseases as HIV and hepatitis. Nucleic-acid based tests for HIV have served as a bold paradigm for how molecular testing can impact the care of patients and as a model for pharmacogenomics. Through...

  • A better way to screen women for gonorrhea.  // Modern Medicine;Nov97, Vol. 65 Issue 11, p8 

    Cites a study from Birmingham, Alabama published in the August 1997 issue of the `Journal of Clinical Microbiology,' highlighting the effectiveness of ligase chain reaction (LCR) assay of vaginal swabs in detecting and ruling out Neisseria gonorrhoea infection. Comparison of LCR's efficacy with...

  • Metody wykrywania wybranych wirusów wywoÅ‚ujÄ…cych zakażenia ukÅ‚adu oddechowego. Stefańska, Ilona; Romanowska, Magdalena; Brydak, Lidia B. // Advances in Hygiene & Experimental Medicine / Postepy Higieny i ;2012, Vol. 66, p452 

    Respiratory viruses contribute to significant morbidity and mortality in healthy and immunocompromised individuals and are considered as a significant economic burden in the healthcare system. The similar clinical symptoms in the course of different viral and bacterial respiratory infections...

  • The Role of Rapid Antigen Testing for Influenza in the Era of Molecular Diagnostics. Dale, Suzanne E. // Molecular Diagnosis & Therapy;Jul2010, Vol. 14 Issue 4, p205 

    Rapid antigen testing for influenza has been both maligned and revered since its conception. Microbiologists have long lamented the lack of sensitivity of commercial rapid influenza detection tests (RIDTs), whereas many clinicians have eschewed their utility by emphasizing the value of...

  • Molecular testing can facilitate diagnosis of respiratory infections. Cox, Amber // Infectious Disease News;Aug2013, Vol. 26 Issue 8, p1 

    The article discusses the reliability of molecular testing in diagnosing respiratory infections, focusing on molecular tests that have been approved by the U.S. Food and Drug Administration, including Luminex xTAG RVP, Luminex RVP FAST, and BioFire FilmArray Respiratory Panel.

  • Light and nanoprobes detect early signs of infection.  // Medical Device Daily;6/28/2013, Vol. 17 Issue 125, Special section p1 

    The article reports on the proof-of-principle approach developed by biomedical engineers and genome researchers from Duke University in Durham, North Carolina, using light to detect infections before patients show symptoms. After its demonstration in human samples, researchers want to place the...

  • Enterococcus QuickFISH Test.  // Monthly Prescribing Reference;Feb2013, Vol. 29 Issue 2, Special section pA-17 

    The reports on the announcement of AdvanDx Inc. regarding the launch of Enterococcus QuickFISH BC, a molecular diagnostic test, for the identification of bloodstream infections caused by Enterococcus.


Other Topics